Skip to content

Canagliflozin

Canagliflozin is a sodium-glucose cotransporter 2 inhibitor. It reduces renal glucose reabsorption, increasing glucose excretion in urine.

Invokana

Type 2 Diabetes Mellitus

100mg

Indicated to address elevated blood glucose to manage diabetes symptoms and alleviate glycaemic strain.

From$4.82/ tabletView

Key points

  • Canagliflozin acts at the kidney’s SGLT2 transporter.
  • Its effects extend to fluid balance and genital or urinary infection risk.

Invokana connects canagliflozin with type 2 diabetes in the diabetes management category. Ketoacidosis, dehydration, genital infections and foot complications are prominent medicine-specific safety topics. They explain the ingredient more usefully than an editorial strength list.

Further reading